Finally, LOX inhibition in transgenic mice developing pancreatic adenocarcinoma prolongs tumor‐free survival and is associated with decreased fibrillar collagen and increased infiltration of macrophages and neutrophils (Miller et al, 2015). Here, LOX is linked to pancreatic adenocarcinoma.